Follow the people · Insider

Renee D. Gala

Insider · President & CEO · JAZZ

Renee D. Gala files insider transactions with the SEC as a president & ceo of Jazz Pharmaceuticals.

Files for 5 companiesJAZZ, DXCM, GOSS, TBPH and 1 more
Disclosed buys and sellsstill being counted — the table below is complete

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 7 May 2020 — 8 September 2026President & CEO · Jazz Pharmaceuticals 39 Form 4 lines · source: SEC Form 4
Filed 6 March 2025 — 28 May 2026Director · Dexcom 4 Form 4 lines · source: SEC Form 4
Filed 10 June 2019 — 8 June 2023Director · Gossamer Bio 5 Form 4 lines · source: SEC Form 4
Filed 3 June 2014 — 20 November 2018SVP, Chief Financial Officer · Theravance Biopharma 26 Form 4 lines · source: SEC Form 4
Filed 27 June 2016 — 20 August 2018Director · Corcept Therapeutics 5 Form 4 lines · source: SEC Form 4

Every transaction

79 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing

Sort byOpen-market trades only79 of 79 shown


8 Sep 2026	10 Sep 2026SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,967 shares	up +2.4%	up +2.2%
8 Sep 2026	10 Sep 2026SEC Form 4	2 d	sold on the open market	Jazz Pharmaceuticals	2,000 shares	up +2.4%	up +2.2%
30 Jun 2026	2 Jul 2026SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	4,835 shares	up +2.0%	up +1.0%
3 Jun 2026	5 Jun 2026SEC Form 4	2 d	gave awaynot a trade	Jazz Pharmaceuticals	600 shares	up +6.4%	up +3.0%
28 May 2026	1 Jun 2026SEC Form 4	4 d	was grantednot a trade	Dexcom	5,605 shares	up +14.8%	up +10.9%
5 Mar 2026	9 Mar 2026SEC Form 4	4 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	7,065 shares	up +33.9%	up +32.6%
5 Mar 2026	9 Mar 2026SEC Form 4	4 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	7,065 shares	up +33.9%	up +32.6%
26 Feb 2026	2 Mar 2026SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	44,465 shares	up +30.1%	up +29.1%
26 Feb 2026	2 Mar 2026SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	44,465 shares	up +30.1%	up +29.1%
16 Jan 2026	21 Jan 2026SEC Form 4	5 d	was grantednot a trade	Jazz Pharmaceuticals	12,741 shares	up +45.1%	up +45.3%
16 Jan 2026	21 Jan 2026SEC Form 4	5 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	5,371 shares	up +45.1%	up +45.3%
16 Jan 2026	21 Jan 2026SEC Form 4	5 d	was grantednot a trade	Jazz Pharmaceuticals	12,741 shares	up +45.1%	up +45.3%
16 Jan 2026	21 Jan 2026SEC Form 4	5 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	5,371 shares	up +45.1%	up +45.3%
5 Dec 2025	9 Dec 2025SEC Form 4	4 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	80 shares	up +44.8%	up +51.5%
7 Aug 2025	11 Aug 2025SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	18,808 shares	up +119.3%	up +121.9%
8 May 2025	7 Jul 2025SEC Form 4	60 d	was grantednot a trade	Dexcom	1,161 shares	down −2.7%	up +0.1%
8 May 2025	12 May 2025SEC Form 4	4 d	was grantednot a trade	Dexcom	5,074 shares	down −2.7%	down −2.4%
6 Mar 2025	10 Mar 2025SEC Form 4	4 d	was grantednot a trade	Dexcom	5,720 shares	up +4.4%	up +17.4%
5 Mar 2025	7 Mar 2025SEC Form 4	2 d	returned to the issuernot a trade	Jazz Pharmaceuticals	5,704 shares	up +75.3%	up +77.1%
27 Feb 2025	3 Mar 2025SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	23,111 shares	up +71.6%	up +75.3%
27 Feb 2025	3 Mar 2025SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	11,555 shares	up +71.6%	up +75.3%
17 Jan 2025	22 Jan 2025SEC Form 4	5 d	was grantednot a trade	Jazz Pharmaceuticals	7,741 shares	up +102.8%	up +103.4%
17 Jan 2025	22 Jan 2025SEC Form 4	5 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	3,300 shares	up +102.8%	up +103.4%
5 Dec 2024	9 Dec 2024SEC Form 4	4 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	80 shares	up +99.6%	up +103.5%
5 Apr 2024	9 Apr 2024SEC Form 4	4 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,736 shares	up +111.1%	up +115.6%
5 Mar 2024	7 Mar 2024SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	3,622 shares	up +107.6%	up +111.2%
1 Mar 2024	5 Mar 2024SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	19,916 shares	up +106.8%	up +107.6%
17 Jan 2024	19 Jan 2024SEC Form 4	2 d	was grantednot a trade	Jazz Pharmaceuticals	7,079 shares	up +108.6%	up +110.9%
17 Jan 2024	19 Jan 2024SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	3,204 shares	up +108.6%	up +110.9%
10 Nov 2023	14 Nov 2023SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	772 shares	up +104.5%	up +97.0%
8 Jun 2023	9 Jun 2023SEC Form 4	1 d	was grantednot a trade	Gossamer Bioderivative	35,000 shares	down −89.4%	down −88.5%
18 May 2023	19 May 2023SEC Form 4	1 d	sold on the open market	Jazz Pharmaceuticals	6,000 shares	up +86.6%	up +83.1%
5 Apr 2023	7 Apr 2023SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,807 shares	up +68.6%	up +67.0%
5 Mar 2023	7 Mar 2023SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,557 shares	up +68.2%	up +76.8%
3 Mar 2023	7 Mar 2023SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	12,784 shares	up +68.2%	up +76.8%
21 Dec 2022	22 Dec 2022SEC Form 4	1 d	sold on the open market	Jazz Pharmaceuticals	2,635 shares	up +55.1%	up +53.8%
9 Jun 2022	15 Jul 2022SEC Form 4	36 d	was grantednot a trade	Gossamer Bioderivative	30,000 shares	down −98.1%	down −98.8%
5 Apr 2022	7 Apr 2022SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,633 shares	up +50.9%	up +45.7%
5 Mar 2022	9 Mar 2022SEC Form 4	4 d	returned to the issuernot a trade	Jazz Pharmaceuticals	720 shares	up +59.2%	up +59.6%
3 Mar 2022	9 Mar 2022SEC Form 4	6 d	was grantednot a trade	Jazz Pharmaceuticals	11,730 shares	up +60.8%	up +59.6%
9 Jun 2021	10 Jun 2021SEC Form 4	1 d	was grantednot a trade	Gossamer Bioderivative	23,500 shares	down −98.5%	down −98.5%
5 Apr 2021	7 Apr 2021SEC Form 4	2 d	had shares withheld for taxnot a trade	Jazz Pharmaceuticals	1,515 shares	up +49.2%	up +51.8%
25 Feb 2021	1 Mar 2021SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	10,115 shares	up +44.0%	up +45.6%
17 Jun 2020	18 Jun 2020SEC Form 4	1 d	was grantednot a trade	Gossamer Bioderivative	23,500 shares	down −98.9%	down −98.9%
7 May 2020	11 May 2020SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticals	16,600 shares	up +124.6%	up +115.0%
7 May 2020	11 May 2020SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticalsderivative	3,652 shares	up +124.6%	up +115.0%
7 May 2020	11 May 2020SEC Form 4	4 d	was grantednot a trade	Jazz Pharmaceuticalsderivative	37,848 shares	up +124.6%	up +115.0%
10 Jun 2019	11 Jun 2019SEC Form 4	1 d	was grantednot a trade	Gossamer Bioderivative	23,500 shares	down −99.3%	down −99.3%
20 Nov 2018	21 Nov 2018SEC Form 4	1 d	had shares withheld for taxnot a trade	Theravance Biopharma	6,697 shares	down −31.4%	down −33.9%
20 Aug 2018	22 Aug 2018SEC Form 4	2 d	was grantednot a trade	Corcept Therapeuticsderivative	25,000 shares	up +765.0%	up +716.7%
20 Aug 2018	22 Aug 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	6,695 shares	down −36.9%	down −38.9%
15 Aug 2018	16 Aug 2018SEC Form 4	1 d	sold on the open market	Theravance Biopharma	39,839 shares	down −36.6%	down −38.5%
15 Aug 2018	16 Aug 2018SEC Form 4	1 d	sold on the open market	Theravance Biopharma	1,700 shares	down −36.6%	down −38.5%
14 Aug 2018	16 Aug 2018SEC Form 4	2 d	sold on the open market	Theravance Biopharma	2,204 shares	down −38.1%	down −38.5%
20 May 2018	22 May 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	21,230 shares	down −30.0%	down −26.0%
18 May 2018	22 May 2018SEC Form 4	4 d	sold on the open market	Theravance Biopharma	10,000 shares	down −30.0%	down −26.0%
14 May 2018	16 May 2018SEC Form 4	2 d	was grantednot a trade	Theravance Biopharma	33,750 shares	down −33.3%	down −30.1%
7 Mar 2018	7 Mar 2018SEC Form 4	0 d	bought on the open market	Corcept Therapeutics	9,000 shares	up +615.2%	up +615.2%
6 Mar 2018	7 Mar 2018SEC Form 4	1 d	bought on the open market	Corcept Therapeutics	1,000 shares	up +630.5%	up +615.2%
20 Feb 2018	22 Feb 2018SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	5,387 shares	down −41.5%	down −37.1%
12 Feb 2018	14 Feb 2018SEC Form 4	2 d	was grantednot a trade	Theravance Biopharma	9,000 shares	down −40.2%	down −42.1%
20 Nov 2017	22 Nov 2017SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	6,753 shares	down −40.5%	down −39.8%
20 Aug 2017	22 Aug 2017SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	6,752 shares	down −37.9%	down −38.0%
24 May 2017	26 May 2017SEC Form 4	2 d	was grantednot a trade	Corcept Therapeuticsderivative	30,000 shares	up +829.8%	up +817.7%
20 May 2017	23 May 2017SEC Form 4	3 d	had shares withheld for taxnot a trade	Theravance Biopharma	6,753 shares	down −53.8%	down −53.4%
20 Feb 2017	22 Feb 2017SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	10,211 shares	down −49.6%	down −44.8%
6 Feb 2017	8 Feb 2017SEC Form 4	2 d	was grantednot a trade	Theravance Biopharma	9,000 shares	down −45.6%	down −44.4%
20 Nov 2016	22 Nov 2016SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	4,628 shares	down −46.8%	down −41.2%
20 Aug 2016	23 Aug 2016SEC Form 4	3 d	had shares withheld for taxnot a trade	Theravance Biopharma	4,306 shares	down −39.0%	down −39.2%
27 Jun 2016	28 Jun 2016SEC Form 4	1 d	was grantednot a trade	Corcept Therapeuticsderivative	70,000 shares	up +2107.2%	up +2016.1%
20 May 2016	24 May 2016SEC Form 4	4 d	had shares withheld for taxnot a trade	Theravance Biopharma	3,333 shares	down −17.2%	down −20.8%
15 Mar 2016	17 Mar 2016SEC Form 4	2 d	was grantednot a trade	Theravance Biopharma	90,000 shares	up +0.3%	down −4.2%
20 Feb 2016	23 Feb 2016SEC Form 4	3 d	had shares withheld for taxnot a trade	Theravance Biopharma	13,052 shares	up +8.7%	up +18.6%
17 Aug 2015	17 Aug 2015SEC Form 4	0 d	bought on the open market	Theravance Biopharma	5,000 shares	up +40.8%	up +40.8%
13 Aug 2015	17 Aug 2015SEC Form 4	4 d	bought on the open market	Theravance Biopharma	5,000 shares	up +42.2%	up +40.8%
5 Feb 2015	9 Feb 2015SEC Form 4	4 d	was grantednot a trade	Theravance Biopharma	135,000 shares	down −1.7%	down −5.4%
20 Aug 2014	22 Aug 2014SEC Form 4	2 d	had shares withheld for taxnot a trade	Theravance Biopharma	158 shares	down −37.0%	down −40.0%
21 Jul 2014	23 Jul 2014SEC Form 4	2 d	was grantednot a trade	Theravance Biopharmaderivative	85,000 shares	down −47.1%	down −46.8%
3 Jun 2014	5 Jun 2014SEC Form 4	2 d	was grantednot a trade	Theravance Biopharmaderivative	85,000 shares	down −27.6%	down −31.0%

Both percentages are the stock’s move, not Renee D. Gala’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 79 of the 79 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.